Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

The National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes. Key aspects of this opportunity include: • Translation of scientific discoveries and engineering developments into methods or tools • Addressing problems in basic research to understand disease • Applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease • Delivering new capabilities to meet evolving requirements for technologies and methods • Advance of research and delivery of care in pre-clinical, clinical and non-clinical settings